FDA Inspection 1099856 — The Compounding PHY of Beverly Hills
The FDA completed an inspection of The Compounding PHY of Beverly Hills on August 16, 2019 in Beverly Hills, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 16, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Beverly Hills, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1112 | 21 CFR 211.25(a) | Training--operations, GMPs, written procedures |
| 21377 | FDCA 501(a)(2)(A) | Use of non-pharmaceutical grade components |
| 3603 | 21 CFR 211.160(b) | Scientifically sound laboratory controls |